Scientific and regulatory activities initiated by the U.S. food and drug administration to foster approvals of generic dry powder inhalers: Quality perspective.

MLA

El-Gendy, Nashwa, et al. “Scientific and Regulatory Activities Initiated by the U.S. Food and Drug Administration to Foster Approvals of Generic Dry Powder Inhalers: Quality Perspective.” Advanced Drug Delivery Reviews, vol. 189, Oct. 2022, p. 114519. EBSCOhost, https://doi.org/10.1016/j.addr.2022.114519.

APA

El-Gendy, N., Bertha, C. M., Abd El-Shafy, M., Gaglani, D. K., Babiskin, A., Bielski, E., Boc, S., Dhapare, S., Fang, L., Feibus, K., Kaviratna, A., Li, B. V., Luke, M. C., Ma, T., Newman, B., Spagnola, M., Walenga, R. L., & Zhao, L. (2022). Scientific and regulatory activities initiated by the U.S. food and drug administration to foster approvals of generic dry powder inhalers: Quality perspective. Advanced Drug Delivery Reviews, 189, 114519. https://doi.org/10.1016/j.addr.2022.114519

Chicago

El-Gendy, Nashwa, Craig M Bertha, Mohammed Abd El-Shafy, Dhaval K Gaglani, Andrew Babiskin, Elizabeth Bielski, Susan Boc, et al. 2022. “Scientific and Regulatory Activities Initiated by the U.S. Food and Drug Administration to Foster Approvals of Generic Dry Powder Inhalers: Quality Perspective.” Advanced Drug Delivery Reviews 189 (October): 114519. doi:10.1016/j.addr.2022.114519.